Abbott Laboratories filed a 10-Q (Quarterly Report) with the SEC. — Filed Jul 28, 2026 · period ended Jun 30, 2026 · accession 0001628280-26-050134.
Item 2.02 Results of Operations and Financial Condition · Item 9.01 Financial Statements and Exhibits — Filed Jul 16,…
Item 7.01 Regulation FD Disclosure · Item 8.01 Other Events · Item 9.01 Financial Statements and Exhibits — Filed Aug…